We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Glaukos (GKOS) Down 11.1% Since Last Earnings Report: Can It Rebound?
Read MoreHide Full Article
It has been about a month since the last earnings report for Glaukos (GKOS - Free Report) . Shares have lost about 11.1% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Glaukos due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers.
Glaukos Loses 14.3% Despite Narrower Loss in Q1
Shares of Glaukos Corporation have lost 14.3% on May 11, following the company's first-quarter 2021 results.
The company reported first-quarter loss per share of 21 cents, noticeably narrower than the Zacks Consensus Estimate of a loss of 30 cents. Notably, the company had posted a loss per share of 44 cents in the prior-year quarter.
Revenues in Detail
Quarterly net sales were $67.9 million, which surpassed the Zacks Consensus Estimate by 4.9%. On a year-over-year basis, revenues improved 22.8%.
Quarter Details
Gross profit in the first quarter was $51.3 million, up 125.1% year over year. Gross margin was 75.5% of net revenues, up 3430 basis points (bps) on a year-over-year basis.
Operating expenses declined 16.3% to $63.1 million on a year-over-year basis, courtesy of lower selling, general and administrative as well as research and development expenses.
Operating loss in the quarter under review was $11.8 million, significantly narrower than the year-ago quarter’s loss of $52.6 million.
Financial Update
The company exited the first quarter with cash and cash equivalents of $96.6 million, remaining flat on a sequential basis.
During the first quarter, total current assets totaled $474.3 million, compared with $469.4 million in the preceding quarter.
Second Quarter 2021 Guidance
For second-quarter 2021, Glaukos projects net sales between $70 million and $72 million.
How Have Estimates Been Moving Since Then?
In the past month, investors have witnessed an upward trend in fresh estimates. The consensus estimate has shifted 17.68% due to these changes.
VGM Scores
Currently, Glaukos has a great Growth Score of A, though it is lagging a lot on the Momentum Score front with a C. Charting a somewhat similar path, the stock was allocated a grade of D on the value side, putting it in the bottom 40% for this investment strategy.
Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been broadly trending upward for the stock, and the magnitude of these revisions looks promising. Notably, Glaukos has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Glaukos (GKOS) Down 11.1% Since Last Earnings Report: Can It Rebound?
It has been about a month since the last earnings report for Glaukos (GKOS - Free Report) . Shares have lost about 11.1% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Glaukos due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers.
Glaukos Loses 14.3% Despite Narrower Loss in Q1
Shares of Glaukos Corporation have lost 14.3% on May 11, following the company's first-quarter 2021 results.
The company reported first-quarter loss per share of 21 cents, noticeably narrower than the Zacks Consensus Estimate of a loss of 30 cents. Notably, the company had posted a loss per share of 44 cents in the prior-year quarter.
Revenues in Detail
Quarterly net sales were $67.9 million, which surpassed the Zacks Consensus Estimate by 4.9%. On a year-over-year basis, revenues improved 22.8%.
Quarter Details
Gross profit in the first quarter was $51.3 million, up 125.1% year over year. Gross margin was 75.5% of net revenues, up 3430 basis points (bps) on a year-over-year basis.
Operating expenses declined 16.3% to $63.1 million on a year-over-year basis, courtesy of lower selling, general and administrative as well as research and development expenses.
Operating loss in the quarter under review was $11.8 million, significantly narrower than the year-ago quarter’s loss of $52.6 million.
Financial Update
The company exited the first quarter with cash and cash equivalents of $96.6 million, remaining flat on a sequential basis.
During the first quarter, total current assets totaled $474.3 million, compared with $469.4 million in the preceding quarter.
Second Quarter 2021 Guidance
For second-quarter 2021, Glaukos projects net sales between $70 million and $72 million.
How Have Estimates Been Moving Since Then?
In the past month, investors have witnessed an upward trend in fresh estimates. The consensus estimate has shifted 17.68% due to these changes.
VGM Scores
Currently, Glaukos has a great Growth Score of A, though it is lagging a lot on the Momentum Score front with a C. Charting a somewhat similar path, the stock was allocated a grade of D on the value side, putting it in the bottom 40% for this investment strategy.
Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been broadly trending upward for the stock, and the magnitude of these revisions looks promising. Notably, Glaukos has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.